Multi-institutional Analysis of 505 Patients With Coronavirus Disease-2019 Supported With Extracorporeal Membrane Oxygenation: Predictors of Survival

Hall, Celeste A; Jacobs, Jeffrey P.; Stammers, Alfred H.; Louis, James D. St.; Hayanga, J.W. Awori; Firstenberg, Michael S.; Mongero, Linda B.; Tesdahl, Eric A.; Rajagopal, Keshava; Cheema, Faisal H.; Patel, Kirti; Coley, Tom; Sestokas, Anthony K.; Slepian, Marvin J.; Badhwar, Vinay

doi:10.1016/j.athoracsur.2022.01.043

Cited by 21 publications

(44 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[4][5][6][7] We previously published analyses of our initial 32, 100, 200, and then 505 patients with COVID-19 with severe pulmonary compromise supported with ECMO. [8][9][10][11] These prior analyses documented the evolution of the use of ECMO to support patients with COVID-19 and supported the concept that "ECMO facilitates survival of select critically ill patients with COVID-19." [8][9][10][11] Although substantial variation exists in drug treatment of COVID-19, ECMO offers a reasonable rescue strategy.…”

mentioning

confidence: 80%

“…[8][9][10][11] These prior analyses documented the evolution of the use of ECMO to support patients with COVID-19 and supported the concept that "ECMO facilitates survival of select critically ill patients with COVID-19." [8][9][10][11] Although substantial variation exists in drug treatment of COVID-19, ECMO offers a reasonable rescue strategy. [9][10][11] Several analyses have described cohorts of patients with COVID-19 supported with ECMO.…”

mentioning

confidence: 80%

“…[8][9][10][11] Although substantial variation exists in drug treatment of COVID-19, ECMO offers a reasonable rescue strategy. [9][10][11] Several analyses have described cohorts of patients with COVID-19 supported with ECMO. [8][9][10][11][12][13][14][15][16][17] Over the course of the pandemic, as knowledge evolved, multiple changes have occurred in both the strategies for management and the outcomes of treatment.…”

mentioning

confidence: 99%

“…[9][10][11] Several analyses have described cohorts of patients with COVID-19 supported with ECMO. [8][9][10][11][12][13][14][15][16][17] Over the course of the pandemic, as knowledge evolved, multiple changes have occurred in both the strategies for management and the outcomes of treatment. Valuable lessons can be learned from this evolution of treatment and outcomes associated with COVID-19.…”

mentioning

confidence: 99%

See 3 more Smart Citations